{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:21:12Z","timestamp":1761016872553},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T00:00:00Z","timestamp":1226448000000},"content-version":"vor","delay-in-days":9904,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[1981,10]]},"abstract":"<jats:sec><jats:title>SUMMARY<\/jats:title><jats:p>Eighteen infants with infantile spasms were given sodium dipropylacetate at a dosage of 20mg\/kg\/day. They were clinically examined before treatment, and again after one to three years of therapy. The short\u2010term clinical response was excellent in four patients, good in eight, poor in four and there was no change in two.<\/jats:p><jats:p>At follow\u2010up, two patients were clinically normal, but 10 had severe and six had moderate mental retardation. Seven patients still had residual seizures. Since these results do not differ significantly from those obtained with hormonal treatment, the authors suggest using sodium dipropylacetate (which has less frequent and less severe side\u2010effects than adreno\u2010corticotropic hormone) as the only initial drug, and to use hormonal treatment only in unresponsive patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>R\u00c9SUM\u00c9<\/jats:title><jats:p>Traitement des spasmes infantiles par l'acide dipropyl\u2010ac\u00e9tique\u2010sodium<\/jats:p><jats:p>10 enfants pr\u00e9sentant des spasmes infantiles ont re\u00e7u du dipropyl\u2010ac\u00e9tate de sodium \u00e0 la dose journali\u00e8re de 20mg\/kg. lis ont \u00e9t\u00e9 examines cliniquement avant le traitement et de nouveau apres un \u00e0 trois ans de traitement. La r\u00e9ponse clinique \u00e0 court terme \u00e0\u00e9t\u00e9 excellente chez quatre nourrissons, bonne chez huit, mediocre chez quatre et nulle chez deux. Aux examens ulterieurs, deux nourrissons etaient cliniquement normaux, dix avaient un retard mental severe et six un retard modere. Sept malades presentaient encore des crises. Puisque ces r\u00e9sultats ne different pas significativement de ceux obtenus par le traitement hormonal, les auteurs proposent d'utiliser le dipropyl\u2010acetate de sodium (qui \u00e0 des effets secondaires moins fr\u00e9quents et moins graves que l'ACTH) comme seule m\u00e9dication initiate et de n'utiliser le traitement hormonal qu'en cas d'\u00e9chec.<\/jats:p><\/jats:sec><jats:sec><jats:title>ZUSAMMENFASSUNG<\/jats:title><jats:p>Therapieempfehlung bei BNS\u2010Kr\u00e4mpfen: Sodium Dipropylacetat<\/jats:p><jats:p>18 Kinder mit BNS\u2010Krampfen wurden mit Sodium Dipropylacetat in einer Dosierung von 20mg\/kg\/Tag behandelt. Sie wurden vor Therapiebeginn und ein bis drei Jahre danach klinische untersucht. Der klinische Erfolg war bei vier Patienten sehr gut, bei acht gut, bei vier schlecht und bei zwei \u00e4nderte sich nichts.<\/jats:p><jats:p>Bei einer Nachuntersuchung waren zwei Patienten klinisch normal, aber 10 hatten schwere und sechs m\u00e4\u00dfige geistige Retardierungen. Sieben Patienten hatten noch gelegentlich Krampfe. Da sich diese Ergebnisse nicht signifikant von denen unterscheiden, die unter hormoneller Therapie erzielt wurden, schlagen die Autoren vor, initial nur Sodium Dipropylacetat einzusetzen (was weniger und geringere Nebenwirkungen hat als ACTH) und die Hormonbehandlung nur bei den Kindern anzuwenden, die auf Sodium\u2010Dipropylacetat nicht ansprechen.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESUMEN<\/jats:title><jats:p>Tratamiento propuesto de los espasmos infantiles con la'sal s\u00f3dica del dcido dipropil\u2010ac\u00e9tico<\/jats:p><jats:p>A dieciocho lactantes con espasmos infantiles se les di\u00f3 dipropil\u2010acetato s\u00f3dico \u00e0 dosis de 20mg\/kg\/dia. Fueron examinados clinicamente antes y y tras uno \u00e0 tres a\u00f1os de tratamiento. La respuesta clinica \u00e0 corto plazo fu\u00e9 excelente en cuatro pacientes, buena en ocho, pobre en cuatro y sin ning\u00fan cambio en dos.<\/jats:p><jats:p>En el curso posterior, dos pacientes estaban clinicamente normales, pero 10 tenian retraso mental grave y seis lo ten\u00edan moderado. Siete pacientes ten\u00edan a\u00fan crisis residuales. Puesto que estos resultados no diferian significativamente de los obtenidos con tratamiento hormonal, los autores sugieren la utilizati\u00f3n del propil\u2010acetato s\u00f3dico (que tiene efectos secundarios menos frecuentes y graves que la hormona adreno\u2010cortico\u2010tropa) como el \u00fanico f\u00e1rmaco inicial y usar el tratamiento hormonal solo en pacientes que no respondan al tratamiento.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1469-8749.1981.tb02018.x","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T06:18:14Z","timestamp":1279174694000},"page":"454-461","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Treatment of Infantile Spasms with Sodium Dipropylacetic Acid"],"prefix":"10.1111","volume":"23","author":[{"given":"Lorenzo","family":"Pavone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Incorpora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario La","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore Li","family":"Volti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florindo","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,11,12]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1015","article-title":"Les spasmes infantiles","volume":"35","author":"Aicardi J.","year":"1978","journal-title":"Archives Francoises de Pediatric"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1975.tb03469.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91885-3"},{"key":"e_1_2_1_5_1","volume-title":"Traitement des spasmes infantiles par les corticosteroides. Revue critique de la litterature","author":"Chevrie J. J.","year":"1979"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1978.tb15250.x"},{"key":"e_1_2_1_7_1","first-page":"273","article-title":"Valproic acid and fatal hepatitis","volume":"29","author":"Donat J. F.","year":"1979","journal-title":"Neurology."},{"key":"e_1_2_1_8_1","first-page":"901","article-title":"Sur les r\u00e9sultats obtenus avec le Depakine dans les epilepsies resistantes aux autres therapies","volume":"69","author":"Dumon\u2010Radermecker M.","year":"1969","journal-title":"Acta Neurologica Belgica"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5783.323"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1970.tb01934.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1973.tb03952.x"},{"key":"e_1_2_1_12_1","unstructured":"Kellaway P.(1978) \u2018Infantile spasms and atonic myoclonic seizures.Proceedings of the American Academy of Neurology Los Angeles pp.1\u201315."},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1542\/peds.65.1.81","article-title":"West syndrome and Lennox\u2010Gastaut syndrome: \u00e0 survey of natural history","volume":"65","author":"Kurukawa T.","year":"1980","journal-title":"Pediatrics"},{"key":"e_1_2_1_14_1","first-page":"79","volume-title":"Infantile Spasms","author":"Lacy J. R.","year":"1976"},{"key":"e_1_2_1_15_1","first-page":"860","article-title":"Sodium valproate in epilepsy","volume":"2","author":"Lancet Editorial","year":"1977","journal-title":"Lancet."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410050414"},{"key":"e_1_2_1_17_1","first-page":"87","article-title":"Action du dipropylacetate de sodium sur certaines varietes \u010fencephalopathies epileptogenes du nourrison","volume":"99","author":"Olive D.","year":"1969","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"e_1_2_1_18_1","unstructured":"Prats\u2010Viflas J. Perales\u2010Ayala M. Rua M. Santolaya J.(1979) \u2018Le traitment du syndrome de West par I'acide dipropilacetyque.Seme Reunion Societe Neurologic InfantileLisbon."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91187-X"},{"key":"e_1_2_1_20_1","first-page":"109","article-title":"Zur Wirksamkeit von Ergenyl (Dipropylazetat) bei Blitz\u2010Nick und Salaamkr\u00e4mpfen","volume":"44","author":"Rohmann E.","year":"1976","journal-title":"Kinderdrzliche Praxis."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6153.1683"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1975.tb04738.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1967.03130030068020"},{"key":"e_1_2_1_24_1","first-page":"130","article-title":"A propos de 21 cas \u010fhypsarythmie de Gibbs: son traitment spectaculaire par \u013eACTH","volume":"58","author":"Sorel L.","year":"1958","journal-title":"Acta Neurologica et Psychiatrica Belgica"},{"key":"e_1_2_1_25_1","first-page":"161","article-title":"Thrombozytenwerte unter Ergenyl","volume":"151","author":"Stolzis L.","year":"1975","journal-title":"Biblioteca Psvchiatrica (Basel)."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197904263001706"},{"key":"e_1_2_1_27_1","first-page":"411","article-title":"Veranderungen der Hamostase bei Epilepsie Behandlung mit Dipropylessigaaure.Erweiterte Untersuchung","volume":"94","author":"Sutor A. H.","year":"1976","journal-title":"Fortschritte der Medizin."},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1979.02130030050008"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1973.tb03955.x"},{"key":"e_1_2_1_30_1","first-page":"1397","article-title":"Side effects of sodium valproate (sodium di\u2010N\u2010propylacetate) on malonyldialdehyde production and other platelet function tests","volume":"30","author":"Voss H.","year":"1978","journal-title":"Minerva Pediatrica"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6042.981"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.1981.tb02018.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.1981.tb02018.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:53:30Z","timestamp":1699124010000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.1981.tb02018.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1981,10]]}},"alternative-id":["10.1111\/j.1469-8749.1981.tb02018.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.1981.tb02018.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,10]]},"assertion":[{"value":"2008-11-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}